Solchenberger, H.;                     Odendahl, M.;                     Schriefer, D.;                     Proschmann, U.;                     Rahbani, G.K.a.;                     Ziemssen, T.;                     Akgün, K.    
        Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens 2025, 14, 235.
    https://doi.org/10.3390/pathogens14030235
    AMA Style
    
                                Solchenberger H,                                 Odendahl M,                                 Schriefer D,                                 Proschmann U,                                 Rahbani GKa,                                 Ziemssen T,                                 Akgün K.        
                Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens. 2025; 14(3):235.
        https://doi.org/10.3390/pathogens14030235
    
    Chicago/Turabian Style
    
                                Solchenberger, Hannah,                                 Marcus Odendahl,                                 Dirk Schriefer,                                 Undine Proschmann,                                 Georges Katoul al Rahbani,                                 Tjalf Ziemssen,                                 and Katja Akgün.        
                2025. "Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs" Pathogens 14, no. 3: 235.
        https://doi.org/10.3390/pathogens14030235
    
    APA Style
    
                                Solchenberger, H.,                                 Odendahl, M.,                                 Schriefer, D.,                                 Proschmann, U.,                                 Rahbani, G. K. a.,                                 Ziemssen, T.,                                 & Akgün, K.        
        
        (2025). Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Pathogens, 14(3), 235.
        https://doi.org/10.3390/pathogens14030235